Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: J Matern Fetal Neonatal Med. 2013 Dec 16;27(14):1422–1427. doi: 10.3109/14767058.2013.866645

Table 3.

Comparison of contraction parameters in cases and controls

Adverse neonatal outcome*
n= 183
Absence of adverse neonatal outcome*
n= 2172
OR (95% CI) p aOR (95% CI) p
Frequency
Average contraction frequency 4.3 +/− 1.1 4.2 +/− 1.0 - 0.26 - -
% of women with >5 contractions/10 minutes 39 (21.3) 331 (15.2) 1.51 (1.01–2.21) 0.03 1.62 (1.11–2.37) 0.01
% of women with ≥5 contractions/10 minutes 63 (34.4) 553 (25.5) 1.54 (1.10–2.14) 0.01 1.64 (1.18–2.27) <0.01
% of women with ≥4 contractions/10 minutes 118 (64.5) 1469 (68.9) 0.82 (0.59–1.14) 0.22 0.90 (0.65–1.24) 0.51
Duration
Average duration of contractions (sec) 81 +/− 13 83 +/− 13 - 0.16 - -
Relaxation time
Average relaxation time (total sec in 10 min) 283 +/− 102 271 +/− 88 - 0.08 - -
Montevideo units (mmHg)
Average Montevideo units 200 +/− 89 208 +/− 87 - 0.22 - -
% of women with average Montevideo units ≤200 95 (41.9) 997 (45.9) 1.27 (0.93–1.73) 0.12 1.21 (0.89–1.65) 0.22
% of women with average Montevideo units >300 27 (14.8) 306 (14.1) 1.06 (0.66–1.63) 0.80 1.02 (0.66–1.57) 0.92
Baseline tone (mmHg)
Average baseline uterine tone +/− SD 24.7 +/− 8.4 23.6 +/− 8.1 - 0.08 - -
% of women with average baseline tone > 20 mmHg 130 (71.0) 1431 (65.9) 1.27 (0.90–1.81) 0.16 1.23 (0.88–1.72) 0.23
*

Data presented as n (%) except continuous variables which are presented as mean +/− standard deviation

Adjusted for oxytocin use, nulliparity, and mode of delivery

Adjusted for nulliparity, and mode of delivery